Stock listing

Dusseldorf:CY71 Anixa Biosciences, Inc. Aktie

German listing (Dusseldorf) of Anixa Biosciences, Inc. · home listing NASDAQ:ANIX

Follow Anixa Biosciences, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:ANIX

$2.61 USD -0.06 (-2.2%)

Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ANIX

Since Jul 6, 2026 -14.4% · daily closes, Jul 6, 2026 – Oct 19, 2026, adjusted for splits
Day range
$2.61 – $2.69 USDOct 19, 2026
Volume
91,260 sharesOct 19, 2026
Market value
$90.73M USDAt the close on Oct 19, 2026 · price × 34.76M shares outstanding
Anixa Biosciences, Inc. logo
Ticker
Dusseldorf:CY71
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Dusseldorf
Currency
EUR

What changed lately

Latest news

Join Anixa Biosciences' Live Investor Webinar: Advancing Innovative CAR-T Therapy for Ovarian Cancer and a First-in-Class Breast Cancer Vaccine

Oct 13, 2026

Anixa Biosciences' Ovarian Cancer CAR-T Therapy Inventor to Deliver Keynote at Ovarian Cancer Midwest Focus Conference

Oct 13, 2026

Anixa Biosciences Announces First Case of Stable Disease for Three Months in Ovarian Cancer CAR-T Clinical Trial

Oct 5, 2026

Anixa Biosciences Announces Treatment of Second Patient in the Fifth Cohort of its Ovarian Cancer CAR-T Clinical Trial

Oct 1, 2026

Anixa Biosciences Granted First Australian Patent for its Breast Cancer Vaccine, Broadening Global Protection Through 2040

Sep 21, 2026

Anixa Biosciences Appoints UPenn's Dr. Carmen Guerra to Cancer Business Advisory Board

Sep 16, 2026

Anixa Biosciences Interview Highlighting Breast Cancer Vaccine to Air on the RedChip Small Stocks, Big Money™ Show on Bloomberg TV

Sep 9, 2026

Anixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026

Sep 3, 2026

Anixa Biosciences to Present at the 2026 Cantor Fitzgerald Global Healthcare Conference Highlighting its Breast Cancer Vaccine and Ovarian Cancer CAR-T Therapy

Aug 24, 2026

Anixa Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Aug 18, 2026

All Anixa Biosciences, Inc. news

Decks

Anixa Biosciences, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
43 in the last 12 months · 182 in all · newest Oct 13, 2026 · oldest 2019
Decks
16 decks · latest September 2026

Where Anixa Biosciences, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:ANIX · Home listingNASDAQUnited StatesUSD
gettex:CY71gettexGermanyEUR
LS Exchange:A2N6ZFLS ExchangeGermanyEUR
Lang & Schwarz:A2N6ZFLang & SchwarzGermanyEUR
Frankfurt:CY71FrankfurtGermanyEUR
Tradegate:CY71TradegateGermanyEUR
BOATS:ANIXBOATSUnited StatesUSD
Munich:CY71MunichGermanyEUR
Dusseldorf:CY71 · This pageDusseldorfGermanyEUR
Hamburg:CY71HamburgGermanyEUR
Stuttgart:CY71StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Anixa Biosciences, Inc.